[Therapy of abdominal complaints suspected to be of biliary origin].
In 37 patients suffering from functional disorders of the bile duct, a multicenter collective blind study was carried out with Hyoscine-N-butyl-bromide (HBB) sugar-coated tablets (5 X 20 mg/daily), and compared with a placebo in a randomized sequence. A statistically significant therapeutic effect with HBB was confirmed on the second day of treatment both by patients and physicians. The duration of treatment seems to be an important parameter as far as the action of HBB is concerned. No atropine-like side effects occurred.
D001965:Bromides / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D005705:Gallbladder Diseases / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D010919:Placebos; D012601:Scopolamine / Q000627:therapeutic use*
D001965:Bromides; D010919:Placebos; D012601:Scopolamine
Beitrag zur Therapie von Abdominalbeschwerden mitVerdacht auf biliären Ursprung